Almenoff June Sherie 4
4 · Avalo Therapeutics, Inc. · Filed Nov 14, 2024
Insider Transaction Report
Form 4
Almenoff June Sherie
Director
Transactions
- Purchase
Common Stock
2024-11-12$12.50/sh+500$6,250→ 500 total(indirect: By LLC) - Purchase
Common Stock
2024-11-13$13.00/sh+500$6,500→ 1,000 total(indirect: By LLC)
Footnotes (2)
- [F1]This transaction was executed in multiple trades ranging from $12.00 to $12.50. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.